HRT Financial’s Theratechnologies THTX Stock Holding History

HRT Financial’s Portfolio THTX Stock Details THTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,185	Closed	-$18K	–	3377
2024 Q4	$18K	Buy	+10,185	New	+$13.8K	﹤0.01%	2225

Other funds holding THTX

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Hamilton Capital Columbus, Ohio $1.93B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's THTX Position: Q1 2025 in Review

HRT Financial sold out of Theratechnologies (THTX) in Q1 2025, closing a stake of 10,185 shares — an estimated $18K sold.

HRT Financial first reported a position in THTX in Q4 2024 and held it in 1 quarter. The position peaked at $18K in Q4 2024. 39 funds tracked by Wall St. Rank hold THTX as of Q1 2025.

HRT Financial reported no remaining Theratechnologies position as of Q1 2025 after selling out during the quarter.
HRT Financial sold 10,185 Theratechnologies shares in Q1 2025, an estimated $18K.
HRT Financial first reported a position in Theratechnologies in Q4 2024 and held it in 1 quarter.
HRT Financial's Theratechnologies position peaked at $18K in Q4 2024.
39 funds tracked by Wall St. Rank held Theratechnologies as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.